Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-02-11 @ 12:43 PM
Study NCT ID:
NCT01460069
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
2011-10-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
Sponsor:
Annesofie Faurschou
Organization:
Study Overview
Official Title:
The Effect of GLP-1 in Psoriasis
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to investigate the effect of the GLP-1 analogue Victoza® on psoriasis in a double-blinded, randomized placebo-controlled clinical trial.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: